CNE1000026S7
CNE1000026S7
LUOXINPHARMACEUTICAL
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 |
|---|---|---|---|
Market & Enterprise Value | |||
Market Cap | 5.32B EUR | 4.18B EUR | 5.31B EUR |
Enterprise Value | 5.71B EUR | 4.48B EUR | 5.7B EUR |
Valuation Multiples | |||
Trailing P/E | -- | -- | -- |
Forward P/E | -- | -- | -- |
Price to Sales | 2.27x | 1.82x | 2.4x |
Price to Book | 4.72x | 3.71x | 4.83x |
EV/Revenue | 2.44x | 1.95x | 2.58x |
EV/EBITDA | 98.21x | -- | -- |
Price to FCF (P/FCF) | 11.59x | 13.4x | 17.51x |
EV/FCF | 12.45x | 14.37x | 18.81x |
FCF Yield | 8.63% | 7.46% | 5.71% |